Zacks Investment Management Sells 605 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Zacks Investment Management lowered its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 2.0% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 29,591 shares of the medical equipment provider's stock after selling 605 shares during the period. Zacks Investment Management's holdings in Intuitive Surgical were worth $15,445,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Bennett Selby Investments LP lifted its stake in shares of Intuitive Surgical by 3.9% in the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider's stock worth $234,000 after purchasing an additional 17 shares during the period. Onefund LLC boosted its stake in shares of Intuitive Surgical by 1.9% during the 4th quarter. Onefund LLC now owns 947 shares of the medical equipment provider's stock worth $494,000 after acquiring an additional 18 shares during the last quarter. LVW Advisors LLC increased its stake in shares of Intuitive Surgical by 1.3% in the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider's stock worth $756,000 after purchasing an additional 19 shares in the last quarter. Wesbanco Bank Inc. lifted its position in Intuitive Surgical by 1.6% during the fourth quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider's stock valued at $635,000 after purchasing an additional 19 shares in the last quarter. Finally, FSM Wealth Advisors LLC increased its position in Intuitive Surgical by 3.7% in the fourth quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider's stock worth $275,000 after buying an additional 19 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company's stock.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on ISRG. Royal Bank of Canada increased their target price on shares of Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. Wells Fargo & Company raised their price objective on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an "overweight" rating in a research report on Friday, January 24th. UBS Group upped their target price on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a "neutral" rating in a report on Monday, January 27th. CICC Research began coverage on Intuitive Surgical in a report on Monday, January 27th. They set a "neutral" rating and a $550.00 price target on the stock. Finally, Bernstein Bank upped their price objective on Intuitive Surgical from $655.00 to $700.00 and gave the stock an "overweight" rating in a research note on Monday, January 27th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat.com, Intuitive Surgical has an average rating of "Moderate Buy" and a consensus target price of $611.81.

Insiders Place Their Bets

In other news, EVP Brian Edward Miller sold 8,900 shares of the company's stock in a transaction that occurred on Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the transaction, the executive vice president now owns 5,758 shares of the company's stock, valued at approximately $2,793,033.06. This represents a 60.72 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, VP Fredrik Widman sold 810 shares of the firm's stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $573.78, for a total value of $464,761.80. Following the sale, the vice president now directly owns 473 shares of the company's stock, valued at $271,397.94. This represents a 63.13 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 33,754 shares of company stock valued at $17,691,621 over the last three months. 0.70% of the stock is owned by company insiders.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock traded up $1.40 on Friday, reaching $482.74. The company had a trading volume of 1,618,989 shares, compared to its average volume of 1,589,481. The firm's 50-day moving average price is $522.23 and its two-hundred day moving average price is $532.34. Intuitive Surgical, Inc. has a 1 year low of $364.31 and a 1 year high of $616.00. The firm has a market cap of $171.94 billion, a price-to-earnings ratio of 75.31, a P/E/G ratio of 5.85 and a beta of 1.55.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.